Akebia Therapeutics AKBA Q1 2026 Earnings EPS Misses Estimates Amid Quiet Trading Session CNTA Q1 2026 Earnings WiderthanExpected Loss as ClinicalStage Biotech Advances Pipeline Origin Materials ORGN Q4 2025 Earnings Massive EPS Miss Amid No Revenue Reported Stock Rises 268 Service Properties Trust Q1 2026 Earnings Net Loss Widens Sharply Shares Edge Higher Despite Miss CODA Q1 2026 Earnings EPS Beats Estimates by 2658 as Company Maintains Profitability PRLD Q1 2026 Earnings Narrower Loss Than Anticipated as Clinical Pipeline Advances